Jazz Pharmaceuticals plc
JAZZFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Jazz Pharmaceuticals plc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 17, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Jazz Pharmaceuticals plc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-26 · Patil Neena M: Larger than 76 of the 79 other insider sales of Ordinary Shares on file. SEC filing
- 2026-02-26 · Patil Neena M: Larger than 75 of the 79 other insider sales of Ordinary Shares on file. SEC filing
- 2026-02-26 · Patil Neena M: Larger than 77 of the 79 other insider sales of Ordinary Shares on file. SEC filing
- 2025-11-26 · COZADD BRUCE C: Larger than 73 of the 79 other insider sales of Ordinary Shares on file. SEC filing
- 2025-11-26 · COZADD BRUCE C: Larger than all 79 other insider sales of Ordinary Shares on file. SEC filing
- 2025-11-26 · COZADD BRUCE C: Larger than 78 of the 79 other insider sales of Ordinary Shares on file. SEC filing
- 2025-11-18 · COZADD BRUCE C: Larger than 74 of the 79 other insider sales of Ordinary Shares on file. SEC filing
- 2025-11-17 · Iannone Robert: Larger than 72 of the 79 other insider sales of Ordinary Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-15 | Smith Mark Douglas · Director | Ordinary Shares | S — Open market or private sale | −1,157 | 230.55 | SEC filing |
| 2026-06-10 | Patil Neena M · EVP & Chief Legal Officer | Ordinary Shares | S — Open market or private sale | −1,200 | 231.83 | SEC filing |
| 2026-06-01 | COZADD BRUCE C · Director | Ordinary Shares | S — Open market or private sale | −6,000 | 235.12 | SEC filing |
| 2026-05-28 | Patil Neena M · EVP & Chief Legal Officer | Ordinary Shares | S — Open market or private sale | −1,192 | 236.97 | SEC filing |
| 2026-05-28 | Pearce Samantha · EVP, Chief Commercial Officer | Ordinary Shares | S — Open market or private sale | −6,907 | 235.41 | SEC filing |
| 2026-05-22 | McSharry Heather Ann · Director | Ordinary Shares | S — Open market or private sale | −2,000 | 241.00 | SEC filing |
| 2026-05-22 | Winningham Rick E · Director | Ordinary Shares | S — Open market or private sale | −2,741 | 241.57 | SEC filing |
| 2026-05-01 | COZADD BRUCE C · Director | Ordinary Shares | S — Open market or private sale | −6,000 | 203.33 | SEC filing |
Showing 8 of 15 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-03 | GALA RENEE D · President & CEO | Ordinary Shares | G — Bona fide gift | −600 | SEC filing |
| 2026-05-28 | Mulligan Seamus · Director | Ordinary Shares | M — Exercise or conversion of derivative security | +3,415 | SEC filing |
| 2026-05-28 | Mulligan Seamus · Director | Non-Qualified Stock Option (right to buy) | M — Exercise or conversion of derivative security | −3,415 | SEC filing |
| 2026-05-28 | Pearce Samantha · EVP, Chief Commercial Officer | Ordinary Shares | M — Exercise or conversion of derivative security | +6,907 | SEC filing |
| 2026-05-28 | Pearce Samantha · EVP, Chief Commercial Officer | Non-Qualified Stock Option (right to buy) | M — Exercise or conversion of derivative security | −6,907 | SEC filing |
| 2026-05-22 | Winningham Rick E · Director | Ordinary Shares | M — Exercise or conversion of derivative security | +3,415 | SEC filing |
| 2026-05-22 | Winningham Rick E · Director | Non-Qualified Stock Option (right to buy) | M — Exercise or conversion of derivative security | −3,415 | SEC filing |
| 2026-03-05 | Johnson Philip L · EVP & Chief Financial Officer | Ordinary Shares | F — Payment of exercise price or tax by delivering securities | −2,615 | SEC filing |
Showing 8 of 31 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-01-16 | Patil Neena M · EVP & Chief Legal Officer | Ordinary Shares | D — Disposition to the issuer | −3,275 | SEC filing |
| 2025-11-19 | Henderson Mary Elizabeth · SVP, Technical Operations | Ordinary Shares | D — Disposition to the issuer | −1,331 | SEC filing |
| 2025-08-18 | ENRIGHT PATRICK G · Director | Ordinary Shares | J — Other acquisition or disposition | −5,000 | SEC filing |
| 2025-03-07 | Henderson Mary Elizabeth · SVP, Technical Operations | Ordinary Shares | D — Disposition to the issuer | −698 | SEC filing |
| 2025-03-07 | Carr Patricia · SVP, Chief Accounting Officer | Ordinary Shares | D — Disposition to the issuer | −1,333 | SEC filing |
| 2025-03-05 | Pearce Samantha · EVP, Chief Commercial Officer | Ordinary Shares | D — Disposition to the issuer | −1,905 | SEC filing |
| 2025-03-05 | GALA RENEE D · President & COO | Ordinary Shares | D — Disposition to the issuer | −5,704 | SEC filing |
| 2025-03-05 | Johnson Philip L · EVP & Chief Financial Officer | Ordinary Shares | D — Disposition to the issuer | −1,149 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.